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Abstract
The prostate is a male accessory sex gland found only in mammals that functions to produce a major fraction of seminal fluid. Interest
in understanding the biology of the prostate is driven both by the fascinating nature of the developmental processes that give rise to the
prostate and by the high incidence in humans of prostatic diseases, including prostatic adenocarcinoma and benign prostatic hyperplasia.
This review summarizes the current state of knowledge of the cellular and molecular processes that control prostatic development. Insight
into the mechanisms that control prostatic development has come from experimental embryological work as well as from the study of mice
and humans harboring mutations that alter prostatic development. These studies have demonstrated a requirement for androgens throughout
prostatic development and have revealed a series of reciprocal paracrine signals between the developing prostatic epithelium and prostatic
mesenchyme. Finally, these studies have identified several specific gene products that are required for prostatic development. While research
in recent years has greatly enhanced our understanding of the molecular control of prostatic development, known genes cannot yet explain
in molecular terms the complex biological interactions that descriptive and experimental embryological studies have elucidated in the control
of prostatic development.
© 2003 Elsevier Science (USA). All rights reserved.
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Overview of prostatic development and structure
Prostatic development
Growth and development of the prostate begin in fetal
life and are complete at sexual maturity. The prostate de-
velops from the urogenital sinus (UGS), a subdivision of the
cloaca. The UGS is a midline structure with an endoder-
mally derived epithelial layer surrounded by a mesoder-
mally derived mesenchymal layer. The UGS is found just
caudal to the neck of the developing bladder (Fig. 1A). The
UGS arises in both male and female mice at approximately
13 days postconception (dpc) and in humans at about 7
weeks of gestation (23 mm; Hamilton et al., 1959). The
male and female urogenital sinuses are morphologically
indistinguishable until about 17.5 dpc in the mouse and
10–12 weeks in humans, at which time prostatic morpho-
genesis commences in a process that is both initiated by and
dependent on circulating androgens produced by the fetal
testes.
The initial event in prostatic morphogenesis is the out-
growth of solid epithelial buds from the urogenital sinus
epithelium (UGE) into the surrounding urogenital sinus
mesenchyme (UGM). Initially, prostatic buds are solid
cords of epithelial cells that grow into the UGM in a precise
spatial pattern that establishes the lobar subdivisions of the
prostate [(Timms et al., 1994a); rodent reviewed in Cunha
et al. (1987); human (Kellokumpu-Lehtonen, 1985; Lows-
ley, 1912)]. In rodents, most of the prostatic ducts are
unbranched at birth. However neonatally, as these ducts
elongate within the UGM, they begin to bifurcate and send
out side-branches. Ultimately, the process of branching
morphogenesis in rats and mice will give rise to three
distinct bilaterally symmetrical prostatic lobes: the anterior
prostate (AP; also known as the coagulating gland), the
dorsolateral prostate (DLP), and the ventral prostate (VP;
Fig. 1B). The ducts of each of these prostatic lobes have a
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characteristic branching pattern (Sugimura et al., 1986a).
Concurrent with the process of ductal branching morpho-
genesis, epithelial and mesenchymal/stromal cytodifferenti-
ation occurs in the first 2–3 weeks after birth in rats and
mice. Epithelial cells of the developing, solid prostatic buds
are characterized by coexpression of cytokeratins 5, 8, 14,
and 18, and p63 (Wang et al., 2001). These solid cords
elongate into the surrounding mesenchyme as a result of
intense proliferative activity at their tips (Sugimura et al.,
1986b). Ductal canalization is initiated in the solid epithelial
cords from their urethral terminus and proceeds distally
toward the ductal tips. As the solid epithelial cords canalize,
the epithelium reorganizes into two distinct cell popula-
tions. Basal epithelial cells become localized along the
basement membrane to form a discontinuous layer of cells
expressing cytokeratins 5 and 14, and p63 in the rat and
mouse. Concomitantly, tall columnar luminal cells, which
express cytokeratins 8 and 18, differentiate and line the
ductal lumina (Hayward et al., 1996a). By this process, the
epithelium of the solid epithelial buds (expressing both
Fig. 1. Morphological and cellular features of the prostate gland. A portion of the urogenital tract from a male embryonic day 16.5 mouse is shown (A). The
prostate develops from the urogenital sinus (UGS), which is located at the base of the developing bladder. At this embryonic stage, the urogenital sinus
epithelium is visible as a dilation of the urethra (lighter area containing *) surrounded on the dorsal and ventral sides by condensed urogenital sinus
mesenchyme (darker areas). The lobes of the adult mouse prostate are shown (B) together with hematoxalin and eosin-stained sections of prostatic ducts from
each lobe (B, inset micrographs). Each lobe has a distinct shape and histologic appearance. A diagram of a ductal cross-section is shown (C) with labels
indicating cell types that are present in prostatic ducts including luminal secretory epithelial cells, basal epithelial cells, neuroendocrine cells, stromal smooth
muscle cells, and stem cell candidates. Beneath the label for each cell type is a list of differentiation markers commonly used to distinguish these cell types.
In the case of stem cell candidates, two studies have associated expression of either a set of markers including cytokeratins 5, 14, 8, 18, and 19, GSTpi, and
p63 (Wang, 2001) or high expression of 21-integrin (Collins, 2001) with rare basal cells proposed as prostatic epithelial stem cell candidates. It is not
currently clear whether the cell type or types from these two studies are identical. Scale bars for photos and micrographs are shown in (A) and (B).
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luminal and basal cell cytokeratins) differentiates into the
distinct luminal and basal cell lineages each expressing their
characteristic subset of cytokeratins. At the same time that
the prostatic epithelium differentiates into distinct basal and
luminal epithelial cell types, the prostatic mesenchyme/
stroma differentiates into a layer of smooth muscle that
surrounds the prostatic ducts (Hayward et al., 1996b).
Branching morphogenesis is almost entirely complete by
2 weeks after birth in the mouse (Sugimura et al., 1986a).
Serum testosterone (T) levels are low during this time, and
the increase in prostatic wet weight is modest. At puberty,
serum T levels rise significantly, and prostatic wet weight
and DNA content increase more rapidly than during the
early postnatal period (Donjacour and Cunha, 1988). Func-
tional cytodifferentiation of luminal epithelial cells occurs
with the expression of the prostate-specific secretory pro-
Fig. 2. Features of prostatic branching morphogenesis. The diagram shows a generic network of developing prostatic ducts. The stage of development, with
solid undifferentiated epithelial cords in the distal region and a forming lumen and cellular differentiation in the proximal region, reflects the early postnatal
period in rodent prostate development. The developing ductal epithelium is shown in green; the developing prostatic mesenchyme is shown in blue; and the
forming ductal lumen is shown in pink. Text annotations indicate general features of prostatic development that have been uncovered by descriptive and
experimental embryological studies. Hormones and gene products that have been implicated in prostate development are also shown with developmental
expression in epithelium or mesenchyme indicated by the location(s) of the gene or hormone symbol. Factors that act positively to promote growth or
morphogenesis of the prostate are shown in black text. Factors that act negatively to limit growth or morphogenesis are shown in red text.
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teins. In mice, prostatic secretory proteins are first detect-
able just prior to puberty (about postnatal day 20) and
greatly increase in abundance as serum T levels rise (Don-
jacour et al., 1990; Mills et al., 1987c). At least two distinct
sets of secretory proteins are expressed by different regions
of the mouse prostate. One group of proteins is secreted by
the VP, and the other by the DLP and AP (Donjacour et al.,
1990; Mills et al., 1987a, b, c). In the human prostate, some
secretory activity is detectable during fetal life (Xia et al.,
1990) presumably due to the action of fetal testicular an-
drogens.
Morphological and cellular structure of the adult prostate
At sexual maturity, the mouse prostate is a multilobed
gland (Fig. 1B) arranged around the urethra at the base of
the bladder. Due to lobe-specific differences in the patterns
of branching morphogenesis, the final shape of each lobe is
distinct. In addition, the lobes have distinct histologic fea-
tures with extensive epithelial-infolding in the AP, signifi-
cant but less extensive epithelial-infolding in the DLP, and
minimal epithelial-infolding in the VP (Fig. 1B, inset).
Regional differences in cell morphology, rates of DNA
synthesis, and secretory activity are also observed along the
proximal–distal (urethra to ductal tip) axis of prostatic ducts
(Lee et al., 1990; Sugimura et al., 1986b). The human
prostate has a more compact adult morphology without
distinct lobes. It is roughly the size and shape of a walnut
(20 g and 4  2.5 cm). The organization of the adult human
prostate is commonly described in terms of three zones: a
central zone, a transition zone, and a peripheral zone, re-
flecting three distinct sets of ducts present in the human
prostate (McNeal, 1983). Comparative observations of pros-
tatic development in rodents and humans demonstrate that
morphogenesis occurs in an analogous manner in both hu-
mans and rodents with several distinct sets of epithelial buds
growing out of the urethra into the UGM (Timms et al.,
1994b). Nevertheless, compelling molecular evidence for
homology between specific rodent prostatic lobes and hu-
man prostatic zones has yet to be identified.
Mature prostatic ducts contain three major cell types,
luminal secretory epithelial cells, basal epithelial cells, and
stromal smooth muscle cells, that can be distinguished by
their patterns of differentiation marker expression (Fig. 1C).
Other less common cell types include neuroendocrine cells
as well as rare basal epithelial cells with unique marker
expression profiles that are candidates for epithelial stem
cells (Fig. 1C; Collins et al., 2001; Wang et al., 2001). The
relative distribution of cell types is somewhat different
between mouse and human prostates. In both species, the
ductal lumen is lined by tall columnar secretory epithelial
cells. These cells have an apical–basal polarity and secrete
prostatic proteins and fluids from their apical surface into
the prostatic lumen. In humans, basal epithelial cells form a
nearly continuous layer between the secretory cells and the
basement membrane, while in mice, fewer basal cells are
present such that they are dispersed as a discontinuous layer
around the ducts. Neuroendocrine cells are present as rare
cells within the epithelial layer of both developing and adult
human prostate. While basal and luminal epithelial cells are
derived from the epithelium of the cloaca, the origin of
neuroendocrine cells is controversial. One hypothesis holds
that neuroendocrine cells share a common progenitor with
secretory cells (Xue et al., 1998). The other hypothesis
posits that neuroendocrine cells are of neural crest origin,
migrating to the UGE through the UGM from the paragan-
glia early in prostatic development (Aumuller et al., 1999).
Neuroendocrine cells have not been extensively studied in
rodents. Rats may not have neuroendocrine cells (Angelsen
et al., 1997), while murine neuroendocrine cells have only
recently been identified in the adult prostate (Garabedian et
al., 1998). Recent research with both mouse and human
prostates has also identified a rare subset of basal cells that
are candidates to be epithelial stem cells (Fig. 1C; Collins et
al., 2001; Wang et al., 2001). In mice, rare basal cells have
been identified with a marker expression profile more char-
acteristic of undifferentiated UGE than the other adult epi-
thelial cell types (Wang et al., 2001). In humans, rare basal
cells have been identified with high expression of 21-
integrin, a marker expressed by putative stem cells in other
tissues (Collins et al., 2001). It is not yet clear if the cell
types described in these two studies are identical.
The stromal layer of both the mouse and the human
prostate is largely composed of smooth muscle. This layer is
much thicker in the human prostate such that the human
prostate has a higher ratio of stromal to epithelial cells than
the mouse. Although mostly smooth muscle, the stromal
layer also contains fibroblastic, neuronal, lymphatic, and
vascular cell types.
Mechanisms of prostatic development
Research into the mechanisms that underlie prostatic
development has been facilitated by the use of experimental
embryological techniques including tissue recombination
and grafting experiments and in vitro organ cultures as well
as by study of mice and humans harboring spontaneous or
engineered mutations. This work has provided insight into
the roles of steroid hormones, cell–cell communication, and
specific gene products in prostatic development.
Roles of steroid hormones in prostatic development
Systemic androgens produced by the fetal testis act to
specify development of the UGS into prostate. In the ab-
sence of androgens, as in females, the UGS forms the lower
portion of the vagina as well as the urethra. Cellular re-
sponse to systemic androgens is mediated by nuclear an-
drogen receptors that are activated by testosterone (T) or
dihydrotestosterone (DHT). The requirement for and suffi-
ciency of androgens in establishing prostate identity in the
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UGS is shown by the absence of a prostate in mice or
humans that lack functional androgen receptors due to in-
activating mutations (Brown et al., 1988; Charest et al.,
1991; Gaspar et al., 1991; He et al., 1991; Lubahn et al.,
1989), and by the development of a prostate in female
urogenital sinuses exposed to androgens (Takeda et al.,
1986). Synthesis of T by the fetal testis begins between 13
and 14 dpc in mice (Pointis et al., 1979, 1980) and around
9 weeks in humans (Siiteri and Wilson, 1974). Testosterone
in fetal circulation is significantly greater in male than
female mice (Pointis et al., 1979, 1980). In the UGS, T
could activate androgen receptors through direct binding to
the androgen receptor and through local conversion of cir-
culating T to the more potent androgen receptor agonist,
DHT, by the enzyme 4-3- ketosteroid-5-reductase (5-
reductase) type 2 (Russell and Wilson, 1994). DHT has a
10-fold greater affinity for the androgen receptor than T
(Deslypere et al., 1992). When conversion of T to DHT is
blocked in the prostate by mutations in the gene encoding
5-reductase type 2, the UGS is specified as prostate but
prostatic growth and development are greatly reduced
(Andersson et al., 1991; Mahendroo et al., 2001). The fact
that blocking conversion of T to DHT in the developing
prostate causes a profound reduction in organ growth and
morphogenesis argues that systemic T (and its subsequent
conversion to DHT) is an important mediator of testicular
androgen synthesis during prostatic development in mice
and humans. The prostatic developmental defects in mice
and humans lacking 5-reductase type 2 further demon-
strate that DHT is a crucial local mediator of testicular
androgen action.
Recently, an investigation of prostate specification in
marsupials has implicated a second testicular androgen,
5-androstane-3, 17-diol (5-adiol), as the circulating
androgen that acts to specify the UGS as prostate (Shaw et
al., 2000). In contrast to the situation in rodents, serum T
levels were not found to be sexually dimorphic in the
marsupial, Macropus eugenii; however, serum 5-adiol lev-
els were found to be higher in males than in females at the
time of prostate specification. In addition, 5-adiol treat-
ment caused female urogenital sinuses to initiate prostatic
development, appearing to act via local conversion of 5-
adiol to DHT by 3-hydroxysteroid dehydrogenase. In the
developing rat prostate, 5-adiol has the potential to stim-
ulate branching morphogenesis in vitro with almost the
same potency as T and DHT (Foster and Cunha, 1999), but
its efficacy at stimulating initial prostatic budding remains
untested. Further work is needed to determine whether 5-
adiol acts together with T as a systemic mediator of testic-
ular androgen synthesis during prostatic development in
mice and humans.
The first known response to androgens by the murine
UGS is the expression of the homeobox gene Nkx3.1 in
patches of urogenital sinus epithelium (UGE) at 15.5 dpc,
which is 2 days before the appearance of prostatic buds
(Sciavolino et al., 1997). The first morphological response
of the murine UGS to androgens is the growth of prostatic
epithelial buds from the UGE into the UGM at around 17.5
dpc. In addition to these early roles in establishing prostatic
identify, androgens are important for stimulating ductal
growth and branching morphogenesis as well as for estab-
lishing functional differentiation of luminal secretory epi-
thelial cells. Tissue recombination and grafting experiments
utilizing urogenital sinuses from Tfm mice that lack andro-
gen receptors have shown that mesenchymal receptors are
required for establishing prostate identity (Bhatia-Gaur et
al., 1999; Cunha and Lung, 1978) and for stimulating ductal
morphogenesis. Epithelial receptors are required for estab-
lishing secretory function in the epithelium (Donjacour and
Cunha, 1993). The fact that mesenchymal but not epithelial
androgen receptors are required for epithelial branching
morphogenesis demonstrates that paracrine signals from the
UGM mediate the action of androgens on the UGE during
prostatic development.
In addition to androgens, prostatic development is very
sensitive to levels of estrogenic compounds. Male embryos
that develop between two females (relative to males that
develop between two males) have higher serum estradiol,
lower serum testosterone, increased expression of the an-
drogen receptor in the prostate, and larger prostates in adult-
hood that arise from more extensive developmental growth
(Timms et al., 1999). Similar prostatic enlargement is ob-
served when male fetuses are exposed to estrogenic com-
pounds at extremely low environmental levels (Nagel et al.,
1999; vom Saal et al., 1997). In contrast, developmental
exposure of males to high levels of estrogenic compounds
causes reduced prostatic growth and altered glandular ar-
chitecture (Prins, 1992). Genetic manipulations of the es-
trogen synthesis pathway in mice that lead to excess or
reduced estrogen levels also affect prostatic size and differ-
entiation (Jarred et al., 2002). It should be noted that, in
each of the cases where changes in estrogen levels were
observed to alter prostatic development, the changes were
systemic and led to complex systemic changes in the overall
endocrine environment. Mice with inactivating mutations in
the known nuclear estrogen receptors, estrogen receptor 
or estrogen receptor , as well as ,  compound mutant
mice have normal prostatic development (Jarred et al.,
2002). Together, these data suggest that prostatic develop-
ment is sensitive to the overall endocrine environment,
including estrogen levels, but local action of the known
nuclear estrogen receptors is not required for prostatic de-
velopment in the context of a normal endocrine environ-
ment.
Epithelial–mesenchymal interactions in prostatic
development
Organogenesis of the prostate is dependent on mesen-
chymal–epithelial interactions such that morphogenesis and
differentiation of both the epithelium and mesenchyme are
abortive if the epithelium and mesenchyme are grown sep-
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arately. The previously mentioned grafting and tissue re-
combination experiments with Tfm mice make clear that the
early developmental effects of androgens on the UGE are
mediated by paracrine signals from the UGM. Additional
grafting and tissue recombination experiments have demon-
strated that paracrine signals from the developing UGM also
direct lobe-specific identity in the juxtaposed epithelium.
Complete UGM as well as the ventral subdivision of the
UGM have been recombined and grafted with a variety of
partner epithelia. Ventral UGM partnered with complete
(dorsal  ventral) UGE forms prostatic ducts that express
secretory proteins characteristic of ventral prostate (Timms
et al., 1995), while complete UGM partnered with adult
ventral epithelium forms prostatic ducts that express secre-
tory proteins characteristic of anterior and dorsolateral pros-
tate as well as ventral prostate (Hayashi et al., 1993). UGM
partnered with embryonic or adult bladder epithelium also
forms prostatic ducts. Grafts in which UGM is partnered
with epithelia from other anatomical locations, including
the seminal vesicle, salivary gland, and esophagus, form
tissues with differentiated epithelia characteristic of the an-
atomical site of origin of the epithelium (Cunha et al.,
1987). These experiments reveal several characteristics of
paracrine signals from the UGM and the competence of
epithelia to respond. First, there are regionally restricted
domains within the UGM that specify a dorsal or ventral
fate for the prostatic epithelium. Second, other epithelial
derivatives of the cloaca (e.g., bladder) can be induced to
form prostate by UGM, but epithelia from other locations
cannot. Third, the potential of heterotypic epithelia to re-
spond to UGM by forming prostatic ducts extends into
adulthood. Together, these results suggest that development
of the prostate is spatially restricted by limited domains of
prostate-inducing paracrine signals in the mesenchyme of
the developing male urogenital tract. Finally, epithelial po-
tential to respond to paracrine signals from the UGM by
forming prostate is restricted to endodermal epithelia with
similar embryonic origin to the prostate. Interestingly, al-
though the morphological form of the prostate varies sig-
nificantly among mammals, the instructive signals from the
UGM are conserved across species lines. This has been
demonstrated by heterospecific tissue recombination and
grafting experiments utilizing tissues from human, mouse,
rabbit, and rat (Aboseif et al., 1999; Cunha et al., 1983).
Additional grafting and tissue recombination experi-
ments have demonstrated that interactions between the de-
veloping prostatic mesenchyme and epithelium are recipro-
cal. Rat UGM has been grafted alone or in combination with
either mouse or human prostatic epithelia. Grafts of UGM
alone formed little smooth muscle. Grafts that included
either mouse or human prostatic epithelia formed a smooth
muscle layer around the prostatic ducts that developed in the
grafts. However, grafts of UGM paired with mouse epithe-
lium formed prostatic ducts surrounded by a thin smooth
muscle layer, i.e., with the mouse stromal architecture. Con-
versely, grafts of UGM paired with human epithelium
formed ducts surrounded by a thick smooth muscle layer,
i.e., with the human stromal architecture (Hayward et al.,
1998). In addition, grafts with human epithelium form a
continuous layer of basal epithelial cells beneath the luminal
secretory epithelial cells, thus recapitulating the prostatic
epithelial architecture found in humans. These experiments
demonstrate that instructive paracrine signals from the pros-
tatic epithelium induce and pattern the surrounding smooth
muscle. They also reveal the presence of intrinsic mecha-
nisms within the epithelium that establish the relative dis-
tribution of basal and luminal epithelial cells.
Molecular control of prostate development
Several genes and gene families have been suggested to
play a role in prostatic development. The evidence for
assigning a developmental role to a particular gene varies
from weak evidence such as descriptive work that shows
that a particular gene is expressed during prostatic develop-
ment to compelling evidence such as a specific prostatic
developmental phenotype caused by inactivating mutations
in the gene. For the purposes of this review, only genes
implicated in prostatic development by work that includes
functional studies on intact animals or functional studies
utilizing primary developing organs, tissues, or cells will be
presented.
The phenotypes of both spontaneous and engineered
mutations in mice and humans have provided direct evi-
dence for the roles of several genes in prostatic development
(summarized in Table 1). In a few cases, experimental
evidence suggests that some of these genes act in redundant
or serial fashion. The homeobox containing transcription
factors HOXA13 and HOXD13 are both required for nor-
mal morphogenesis of the prostate and act in a partially
redundant fashion. Hoxa13/ mice have small prostates
with reduced branching morphogenesis of the VP and DLP
(Podlasek et al., 1999b). Hoxd13/ mice also have a
smaller VP and DLP with reduced DLP branching morpho-
genesis (Podlasek et al., 1997). Compound Hoxa13/:
Hoxd13/ mutant mice have a more severe failure of
prostate development, including the absence of the AP
(Warot et al., 1997). The enzyme 5- reductase type 2
(encoded by the Srd5a2 gene) synthesizes the potent andro-
gen receptor agonist, DHT, from circulating T (Russell and
Wilson, 1994). Similarly, the enzyme 3-hydroxysteroid
dehydrogenase (3-HSD, encoded by the Akr1c4 gene)
synthesizes DHT from circulating 5-adiol. Thus, Srd5a2
and Akr1c4 function upstream of the androgen receptor,
which in turn up-regulates the Shh and Nkx3.1 genes either
directly or indirectly (Podlasek et al., 1999a; Sciavolino et
al., 1997). Furthermore, analysis of Shh/ mice places
SHH upstream of the NKX3.1 transcription factor in pros-
tate development since the UGS of Shh/ mice fails to
express Nkx3.1 transcripts (Schneider et al., 2000).
Additional genes have been implicated in prostate devel-
opment by functional studies based on the manipulation of
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prostatic organ cultures to augment descriptive work. Two
members of the fibroblast growth factor (FGF) family of
secreted proteins, FGF7 and FGF10, are expressed in the
mesenchyme of the developing prostate. These growth fac-
tors are thought to act through FGFR2 expressed by the
prostatic epithelium. Furthermore, work with prostate organ
cultures and isolated prostatic cells suggests that these fac-
tors act to promote prostatic ductal morphogenesis by pro-
moting epithelial proliferation (Sugimura et al., 1996;
Thomson and Cunha, 1999). Analysis of the developmental
expression patterns and effects of recombinant proteins on
in vitro organ cultures have also implicated the secreted
factors activin A and its binding protein follistatin in regu-
lating prostatic morphogenesis (Cancilla et al., 2001). Ac-
tivin A is expressed in both the developing prostatic mes-
enchyme and epithelium; its receptors are expressed in the
epithelium. Follistatin, an activin A antagonist, is also ex-
pressed in the epithelium. Recombinant forms of these pro-
teins have opposing effects with activin A acting to limit,
and follistatin acting to promote epithelial growth and mor-
phogenesis. Hyaluronan, a polysaccharide component of the
extracellular matrix, and its cellular receptor, CD44, have
also been implicated in prostatic morphogenesis. Hyaluro-
nan is present in the mesenchymal matrix of the developing
prostate, and CD44 is expressed by both mesenchymal and
epithelial cells. Treatment of prostatic organ cultures with
agents that antagonize hyaluron/CD44 function including
hyaluronan hexasaccharides, hyaluronidase, and anti-CD44
antibodies all impaired prostatic morphogenesis (Gakunga
et al., 1997). Fucosyltransferase 1, a transmembrane en-
zyme present in the secretory pathway and at the cell sur-
face, is expressed by the developing prostatic epithelium
and plays a role in prostatic development. Inhibitory anti-
bodies directed against fucosyltransferase 1 reduce epithe-
lial proliferation of prostatic organ cultures (Marker et al.,
2001). Interaction between urokinase plasminogen activator
and the membrane urokinase plasminogen activator receptor
also appears to play a pro-differentiation/pro-survival role
during prostatic development as peptides that disrupt this
interaction inhibit growth and differentiation of prostatic
organ cultures with associated increases in apoptosis (Elf-
man et al., 2001).
Major unresolved questions
Many years of descriptive and experimental embryolog-
ical work have provided substantial insight into the roles of
circulating hormones and epithelial–mesenchymal interac-
tions in controlling development of the prostate (Fig. 2). In
recent years, several specific gene products and genetic
pathways have been identified that act at the molecular level
to control some aspects of prostatic development (Table 1
and Fig. 2). Nevertheless, these genes do not explain in
molecular terms the complex biological interactions that
descriptive and experimental embryological studies have
elucidated in the control of prostatic development.
One major unresolved question is the nature of the mes-
enchymal factors that mediate the actions of androgens on
the developing prostatic epithelium. Tissue recombination
and grafting experiments with Tfm mice have demonstrated
that epithelial budding, branching morphogenesis, and early
epithelial differentiation are dependent on mesenchymal
androgen receptors. Consequently, there must be androgen-
dependent paracrine cues from the mesenchyme that direct
epithelial morphogenesis. One current hypothesis holds that
androgen-dependent differences in the differentiation of
smooth muscle within the UGM may play a role in this
paracrine interaction by creating a physical barrier between
the epithelium and constitutive mesenchymal growth factors
in females but not in males (Thomson et al., 2002). How-
ever, the causal relationship between more extensive
smooth muscle differentiation in the female UGM and the
lack of epithelial budding in the female UGE has not yet
been established.
A second major unresolved question is the nature of
factors that control region-specific identity in the prostate.
The different prostatic lobes have different overall shapes
and patterns of branching morphogenesis. They also have
distinct histologic appearances and distinct patterns of se-
cretory protein production. Grafting and tissue recombina-
tion experiments have demonstrated that region specific
identity in the epithelium is established, at least in part, by
paracrine cues from the mesenchyme. Thus, there must
regulatory genes with region-specific expression in both the
prostatic mesenchyme and epithelium as well as region
specific paracrine cues from the mesenchyme to the epithe-
lium. Currently, the only gene that has been specifically
implicated in controlling an aspect of region-specific iden-
tity is Hoxa10 that is expressed in both the mesenchyme and
epithelium of the developing prostate. Mutations in this
gene have been reported to cause a partial transformation of
AP to DLP based on ductal morphology and branching
pattern (Podlasek et al., 1999c). However, this proposed
transformation was incomplete and only partially penetrant.
An important issue related to region-specific identity
within the prostate is whether homology between particular
prostatic lobes in rodents and the prostatic zones in humans
can be established. This issue has direct relevance for un-
derstanding and modeling human prostatic diseases because
prostatic diseases occur in a highly region-specific manner
in humans with prostatic adenocarcinoma predominantly a
disease of the peripheral zone and benign prostatic hyper-
plasia predominantly a disease of the transition zone. Com-
parative anatomical studies of developing and adult human
and rodent prostates have not provided a clear resolution to
this question. The identification and characterization in
mice and humans of the molecular factors that control
region-specific prostate identity is needed.
Finally, descriptive and experimental embryological
studies have shown that there are differences in cellular
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proliferation, secretory activity, and cellular architecture
along the proximal–distal axis of the prostatic ducts as well
as paracrine cues from the epithelium that direct mesenchy-
mal development. None of these features of prostate devel-
opment can currently be explained in molecular terms.
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